Manufacturer record
Fantasy Drugs Private Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Fantasy Drugs Private Limited (Bihar) was declared Not of Standard Quality in December 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CZT-2101, Cifazime-AZ (Cefixime & Azithromycin Tablets) (exp Jan 2023). RDTL Guwahati (state lab) found it not of standard quality: Identification of Azithromycin & Assay of Cefixime & Azithromycin. Listed in the December 2022 alert.
Records by type
1 record linked to Fantasy Drugs Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cifazime-AZ (Cefixime & Azithromycin Tablets) | Batch CZT-2101Mfg Feb 2021 · Exp Jan 2023 | Identification of Azithromycin & Assay of Cefixime & AzithromycinAssay | RDTL GuwahatiState lab | Dec 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.